Pulin Li from Boston, MA, age 41

Methods For Enhancing Hematopoietic Stem/Progenitor Cell Engraftment
view source
US Patent:

20110305676, Dec 15, 2011
Filed:

Feb 3, 2010
Appl. No.:

13/147703
Inventors:

Leonard I. Zon - Wellesley MA, US
Pulin Li - Cambridge MA, US
Assignee:

CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:

A61K 35/14
A61P 7/00
A61K 31/192
A61K 35/28
A61K 31/196
US Classification:

424 937, 514563, 514569
Abstract:

Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using compounds identified using a zebrafish model of hematopoietic cell engraftment. The compounds can be used to treat hematopoietic stem cells ex vivo prior to transplantation of the cells. Alternatively, the compounds can be administered to an individual undergoing cell transplantation.

Methods For Enhancing Hematopoietic Stem/Progenitor Cell Engraftment
view source
US Patent:

20110293582, Dec 1, 2011
Filed:

Feb 3, 2010
Appl. No.:

13/147710
Inventors:

Leonard I. Zon - Wellesley MA, US
Pulin Li - Cambridge MA, US
Assignee:

CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:

A61K 35/28
A61K 31/223
A61K 31/185
A61P 7/00
A61K 31/683
A61K 31/19
A61K 31/195
A61K 31/44
A61K 35/14
A61K 31/192
US Classification:

424 937, 514549, 514578, 514568, 514106, 514557, 514567, 514350
Abstract:

Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using farnesyl compounds identified using a zebrafish model of hematopoietic cell engraftment. The compounds can be used to treat hematopoietic stem cells ex vivo prior to transplantation of the cells. Alternatively, the compounds can be administered to an individual undergoing cell transplantation.

Methods For Enhancing Hematopoietic Stem/Progenitor Cell Engraftment
view source
US Patent:

20170333483, Nov 23, 2017
Filed:

Jul 17, 2017
Appl. No.:

15/651416
Inventors:

- Boston MA, US
Pulin Li - Cambridge MA, US
International Classification:

A61K 35/28
A61K 31/19
C12N 5/0789
A61K 31/255
A61K 31/221
A61K 31/21
A61K 31/095
A61K 35/12
Abstract:

Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using farnesyl compounds identified using a zebrafish model of hematopoietic cell engraftment. The compounds can be used to treat hematopoietic stem cells ex vivo prior to transplantation of the cells. Alternatively, the compounds can be administered to an individual undergoing cell transplantation.

Methods For Enhancing Hematopoietic Stem/Progenitor Cell Engraftment
view source
US Patent:

20150272996, Oct 1, 2015
Filed:

Apr 21, 2015
Appl. No.:

14/691870
Inventors:

- Boston MA, US
Pulin Li - Cambridge MA, US
International Classification:

A61K 35/28
A61K 31/19
C12N 5/0789
A61K 31/221
Abstract:

Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using farnesyl compounds identified using a zebrafish model of hematopoietic cell engraftment. The compounds can be used to treat hematopoietic stem cells ex vivo prior to transplantation of the cells. Alternatively, the compounds can be administered to an individual undergoing cell transplantation.

Methods For Enhancing Hematopoietic Stem/Progenitor Cell Engraftment
view source
US Patent:

20150246075, Sep 3, 2015
Filed:

May 7, 2015
Appl. No.:

14/706560
Inventors:

- Boston MA, US
Pulin Li - Cambridge MA, US
International Classification:

A61K 35/28
A61K 31/19
A61K 31/336
A61K 31/662
A61K 45/06
A61K 31/23
Abstract:

Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using compounds identified using a zebrafish model of hematopoietic cell engraftment. The compounds can be used to treat hematopoietic stem cells ex vivo prior to transplantation of the cells. Alternatively, the compounds can be administered to an individual undergoing cell transplantation.

Pulin Li